Pembrolizumab, Radiotherapy, and Chemotherapy in Neoadjuvant Treatment of Malignant Esophago-gastric Diseases (PROCEED)
Clinical trial NCT03064490 · COMPLETED
Trial details
- NCT number
- NCT03064490
- Sponsor
- Duke University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-17
- Primary completion
- 2023-02-24
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.